From the Desk of Kimmy Sokoloff

We have a big week ahead of us as far as earnings go.

The indices have been holding on for the past two weeks, but we've barely gone anywhere.

You want to talk about trends?

The biggest trend I see is that stocks keep going up in price, but investors are more pessimistic than ever.

I don't understand...

What are people so angry about? Why are they so scared?

Barron's latest Big Money poll shows that out of the 130 managers polled only 6% of their clients were bullish.

lol 6%?

This is the weekly post that aggregates all the charts we put together throughout the week and organizes them all into one, easy to flip through deck.

From the Desk of Ian Culley @IanCulley

The increased selling pressure across grain markets might not be on your radar. 

But pay close attention: The soybean complex, corn, and wheat are edging toward their respective year-to-date lows as demand wanes. 

Even if you don’t trade these ag contracts, fresh multi-month lows – especially in wheat – carry broad implications for equities and cyclical assets. (Hint: It has to do with crude oil.) 

That’s why I’m on high alert for a potential breakdown in Chicago wheat…

Wheat has been in a strong downtrend since its March 2022 peak, entering a bearish momentum regime last summer.

Notice it's currently carving out a potential multi-month reversal pattern below a significant polarity zone.

But the bulls have their work cut out for them, as the bearish momentum profile suggests sellers are still in control of the market. 

When I take a closer look, I see a...

From the Desk of Kimmy Sokoloff

Today was monthly options expiration, and it was slim pickings.

Fridays are always hard to trade, as you can see below: not much movement.

From the Desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. Click here to check it out.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

Click table to enlarge view

We filter out any laggards that are down -5% or more relative to the S&P 500 over the trailing month. 

Then...

Finally, a setup I love that has earnings out of the way! There's light at the end of the tunnel. And no surprise I find this setup in a strong sector that wants to lead the market higher.

We're going to leverage some cheap options to position for a breakout to 52-week highs in this big cap name.

We had a resting GTC order filled at our profit target in the Paid-to-Play portfolio today:

We've adjusted a position in the Paid-to-Play portfolio today:

We had a resting GTC order filled at our profit target in the Paid-to-Play portfolio today:

We had a resting GTC order filled at our profit target in the Paid-to-Play portfolio today:

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management.

Cormorant revealed an additional purchase of $58 million in Ambrx Biopharma $AMAM.